Hydrofarm Holdings

HYFM

Market cap $12.8M

The U.S. cannabis industry continues to grow rapidly as legalization momentum spreads across new states. According to recent data, the market is projected to exceed $35 billion in annual sales by 2025. Additionally, analysts expect the industry to reach over $70 billion by 2030 as federal reform progresses. Last week, renewed discussions in Congress surrounding cannabis rescheduling lifted investor optimism. The Department of Health and Human Services' recommendation to reclassify cannabis also fueled market speculation. As a result, many ancillary stocks—those supporting growers with equipment, nutrients, and hydroponic systems—saw a spike in trading activity. These companies remain essential for industry expansion, offering investors exposure without the risks of direct plant handling.

SHOEMAKERSVILLE, Pa., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (Nasdaq: HYFM) (“Hydrofarm” or the “Company”) a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (“CEA”), today announced that Chris Yetter has been appointed to serve on the Company's Board of Directors (the “Board”) and the Compensation Committee of the Board, effective October 1, 2025.

Most marijuana stock investors are keeping a core focus on the future. At one point in time, most cannabis stocks had fast turnarounds for making a profit. However, this has not been the case for a long while. In fact, since the pandemic, there has been an overwhelming drop in trading in that sector. Now, with a bigger push for federal reform and other rules and regulatory issues being worked on in the last few months, cannabis stocks have been on the rise.

The U.S. cannabis industry continues to expand, with annual sales expected to surpass 40 billion dollars in 2025. Market forecasts suggest long-term growth as more states approve medical and recreational use. Recent discussions on federal legalization have also reignited investor interest. These developments provide a favorable backdrop for ancillary companies, which support the industry without directly handling cannabis. Because they supply cultivators and dispensaries with essential tools, these businesses often face less regulatory risk.

For cannabis investors, watching the industry's growth brings hope. Especially with how volatile the sector can get, even when public companies do well as a business, it does not resonate in the stock market. In recent news, Q2 earnings have been released for most publicly traded cannabis companies. Some companies have reported that they are still generating decent revenue. For others, beyond showing profitability, more partnerships and deals are being made.

Marijuana stock investors are awaiting to hear what will come of cannabis rescheduling. Historically, when news on the matter is released that shows progress, most cannabis stocks begin to trade up. This is what speculation can do. No one wants to be late to invest or miss the chance to be in an emerging sector. Legal cannabis has been on the rise for many years. Facing many roadblocks and still finds a way to forge ahead.

Hydrofarm Holdings Group, Inc. (HYFM) came out with a quarterly loss of $3.63 per share versus the Zacks Consensus Estimate of a loss of $2.39. This compares to a loss of $2.8 per share a year ago.

Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM ) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants B. John Lindeman - CEO & Director Kevin Patrick O'Brien - Chief Financial Officer Conference Call Participants Dmitry Silversteyn - Water Tower Research LLC John Di Domenico - Unidentified Company Operator Good day, ladies and gentlemen, and thank you for standing by.

The U.S. cannabis industry remains a powerful economic force, generating over $30 billion in annual sales in 2024. Industry analysts project sales could exceed $50 billion by 2030, driven by expanding legalization and rising consumer demand. Recently, headlines have focused on federal reform momentum after bipartisan discussions in Congress. These talks aim to improve banking access for cannabis businesses, which could boost profitability. Ancillary cannabis companies, which supply products and services to cultivators and retailers, continue to benefit from sector growth. They avoid direct plant-touching risks while capturing steady revenue from equipment, supplies, and technology demand. Consequently, these stocks can provide diversified exposure to the market.

SHOEMAKERSVILLE, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, today announced financial results for its second quarter ended June 30, 2025.